• 1
    Chavakis E, Koyanagi M, Dimmeler S. Enhancing the outcome of cell therapy for cardiac repair: Progress from bench to bedside and back. Circulation 2010;121:325335.
  • 2
    Mangi AA, Noiseux N, Kong D et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:11951201.
  • 3
    Quevedo HC, Hatzistergos KE, Oskouei BN et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci 2009;106:1402214027.
  • 4
    Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 2012;110:624637.
  • 5
    Williams AR, Hare JM. Mesenchymal stem cells. Circ Res 2011;109:923940.
  • 6
    Wollert KC, Drexler H. Cell therapy for the treatment of coronary heart disease: A critical appraisal. Nat Rev Cardiol 2010;7:204215.
  • 7
    Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1E7.
  • 8
    Gallagher KA, Liu ZJ, Xiao M et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1{alpha}. J Clin Invest 2007;117:12491259.
  • 9
    Turgeon J, Dussault S, Haddad P et al. Probucol and antioxidant vitamins rescue ischemia-induced neovascularization in mice exposed to cigarette smoke: Potential role of endothelial progenitor cells. Atherosclerosis 2010;208:342349.
  • 10
    Heida NM, Müller JP, Cheng IF et al. Effects of obesity and weight loss on the functional properties of early outgrowth endothelial progenitor cells. J Am Coll Cardiol 2010;55:357367.
  • 11
    Vajkoczy P, Blum S, Lamparter M et al. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 2003;197:17551765.
  • 12
    Ryzhov S, Solenkova NV, Goldstein AE et al. Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells. Circ Res 2008;102:356363.
  • 13
    Zemani F, Silvestre JS, Fauvel-Lafeve F et al. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol 2008;28:644650.
  • 14
    Haider HK, Jiang S, Idris NM et al. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1{alpha}/CXCR4 signaling to promote myocardial repair. Circ Res 2008;103:13001308.
  • 15
    Pfosser A, El-Aouni C, Pfisterer I et al. NF kappaB activation in embryonic endothelial progenitor cells enhances neovascularization via PSGL-1 mediated recruitment: Novel role for LL37. Stem Cells 2010;28:376385.
  • 16
    Zernecke A, Schober A, Bot I et al. SDF-1{alpha}/CXCR4 axis is instrumental in murine neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005;96:784791.
  • 17
    Malik M, Chen YY, Kienzle MF et al. Monocyte migration and LFA-1-mediated attachment to brain microvascular endothelia is regulated by SDF-1+alpha through Lyn kinase. J Immunol 2008;181:46324637.
  • 18
    Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011;146:873887.
  • 19
    Jain RK. Molecular regulation of vessel maturation. Nat Med 2003;9:685693.
  • 20
    Schierling W, Troidl K, Troidl C et al. The role of angiogenic growth factors in arteriogenesis. J Vasc Res 2009;46:365374.
  • 21
    Hershey JC, Baskin EP, Corcoran HA et al. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits. Heart Vessels 2003;18:142149.
  • 22
    Kupatt C, Hinkel R, Pfosser A et al. Cotransfection of vascular endothelial growth factor-a and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion: Role of vessel maturation. J Am Coll Cardiol 2010;56:414422.
  • 23
    Hatzopoulos AK, Folkman J, Vasile E et al. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 1998;125:14571468.
  • 24
    Kupatt C, Horstkotte J, Vlastos GA et al. Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia. FASEB J 2005;19:15761578.
  • 25
    Hinkel R, Trenkwalder T, Pfosser A et al. Therapeutic neovascularization via Thymosin beta4 overexpression requires AKT activation and capillary sprouting in the calf muscles: Evidence for backward signaling. Cardiovasc Res 2010;87:S59.
  • 26
    Massberg S, Konrad I, Schurzinger K et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 2006;203:12211233.
  • 27
    Langer H, May AE, Daub K et al. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 2006;98:e210.
  • 28
    Notohamiprodjo M, Djafarzadeh R, Mojaat A et al. Generation of GPI-linked CCL5 based chemokine receptor antagonists for the suppression of acute vascular damage during allograft transplantation. Protein Eng Des Sel 2006;19:2735.
  • 29
    Pfosser A, El-Aouni C, Pfisterer I et al. NF kappaB activation in embryonic endothelial progenitor cells enhances neovascularization via PSGL-1 mediated recruitment: Novel role for LL37. Stem Cells 2010;28:376385.
  • 30
    Lebherz C, von Degenfeld G, Karl A et al. Therapeutic angiogenesis/arteriogenesis in the chronic ischemic rabbit hindlimb: Effect of venous basic fibroblast growth factor retroinfusion. Endothelium 2003;10:257265.
  • 31
    Schulz C, Schafer A, Stolla M et al. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: A critical role for P-selectin expressed on activated platelets. Circulation 2007;116:764773.
  • 32
    Liehn EA, Tuchscheerer N, Kanzler I et al. Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. J Am Coll Cardiol 2011;58:24152423.
  • 33
    Segers VFM, Tokunou T, Higgins LJ et al. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 2007;116:16831692.
  • 34
    Tsou CL, Haskell CA, Charo IF. Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine. J Biol Chem 2001;276:4462244626.
  • 35
    Hundhausen C, Schulte A, Schulz B et al. Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J Immunol 2007;178:80648072.
  • 36
    Askari AT, Unzek S, Popovic ZB et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003;362:697703.
  • 37
    Zaruba MM, Theiss HD, Vallaster M et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 2009;4:313323.
  • 38
    Levesque JP, Hendy J, Takamatsu Y et al. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003;111:187196.
  • 39
    Aiuti A, Webb IJ, Bleul C et al. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997;185:111120.
  • 40
    Hendrix CW, Collier AC, Lederman MM et al. Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J Acquir Immune Defic Syndr 2004;37:12531262.
  • 41
    Jujo K, Hamada H, Iwakura A et al. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci 2010;107:1100811013.
  • 42
    Abbott JD, Huang Y, Liu D et al. Stromal cell-derived factor-1{alpha} plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004;110:33003305.
  • 43
    Roncalli J, Renault MA, Tongers J et al. Sonic hedgehog-induced functional recovery after myocardial infarction is enhanced by AMD3100-mediated progenitor-cell mobilization. J Am Coll Cardiol 2011;57:24442452.
  • 44
    Ziegler M, Elvers M, Baumer Y et al. The bispecific SDF1-GPVI fusion protein preserves myocardial function after transient ischemia in mice/clinical perspective. Circulation 2012;125:685696.
  • 45
    Hiasa K, Ishibashi M, Ohtani K et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: Next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004;109:24542461.
  • 46
    Tang YL, Zhu W, Cheng M et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circulation Res 2009;104:12091216.
  • 47
    Landsman L, Bar-On L, Zernecke A et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2009;113:963972.
  • 48
    Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27:22922301.
  • 49
    Sata M, Saiura A, Kunisato A et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002;8:403409.
  • 50
    George J, Afek A, Abashidze A et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2005;25:26362641.
  • 51
    Medof ME, Nagarajan S, Tykocinski ML. Cell-surface engineering with GPI-anchored proteins. Faseb J 1996;10:574586.